Apr 16–19, 2026 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
Mathias Lichterfeld, Afam Okoye, Marina F. Caskey, and Caroline T. Tiemessen

-
Scientific Organizers: Mathias Lichterfeld, Afam Okoye, Marina F. Caskey, and Caroline T. Tiemessen
Mathias Lichterfeld
Afam Okoye
Marina F. Caskey
Caroline T. Tiemessen
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandThursday, April 16, 2026
Fundraising
Booking Function
Merchandise Options
Registration Options
Friday, April 17, 2026
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
Promoting Persistent bNAb Expression in NHPs through AAV-Mediated Gene Transfer
Long-acting ART in HIV Prevention and Cure
Vaccination of PLWH, using 426C Derived Immunogens
HIV Reservoir Cell Resistance to Immune-Mediated Killing
HIV-1 Reservoir Dynamics
NK Cell Targeting of the HIV Reservoir
Saturday, April 18, 2026
Optimizing T Cell Responses for Post-ART Control
Immune-Based Cell Therapies
Therapeutic Vaccine Trials in Humans
CRISPR for HIV Cure: Human Clinical Trial Data
Epigenetic Mechanisms of HIV Persistence
The HUSH Complex and HIV Silencing
Sex Differences in HIV Reservoir Cell Persistence
Sunday, April 19, 2026
HIV Immune Responses Across the Age Spectrum
HIV Remission in Infants
Triple Combinations of Broadly-Neutralizing Antibodies in Children
Viral Reservoirs and Immune Responses in Adolescents and Young Adults with HIV
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
Engineering B Cells as in vivo bnAb Factories
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
Monday, April 20, 2026
Subscribe for Updates